CN101940697B

CN101940697B - Medicament for treating prostatitis

Info

Publication number: CN101940697B
Application number: CN201010286779XA
Authority: CN
Inventors: 王之渊
Original assignee: Individual
Current assignee: Individual
Priority date: 2010-09-16
Filing date: 2010-09-16
Publication date: 2011-11-02
Anticipated expiration: 2030-09-16
Also published as: CN101940697A

Abstract

The invention relates to a medicament for treating prostatitis. The medicament is prepared from fish poison yam, grassleaved sweetflag rhizome, bupleurum, Szechwan chinaberry fruit, Indian buead, largehead atractylodes rhizome, red paeony root, white paeony root, peach seed, bitter orange, rhizoma corydalis, tangerine seed, litchi seed and liquoric root, wherein the raw materials is decocted with water to prepare detection; the detection is concentrated into clear cream; and the clear cream is smashed and packed into capsules to obtain the medicament. The medicament has the effects of clearing heat, releasing toxin, inducing diuresis for treating stranguria, soothing lever, regulating qi, invigorating spleen, dispersing dampness, removing blood stasis, relieving pain, tonifying qi, ascending the clear and descending the turbid and promoting qi. The total effective rate reaches 95.0 percent through clinical observation.

Description

The prostatitic medicine of a kind of treatment

Technical field

The present invention relates to the prostatitic medicine of a kind of treatment, particularly relating to a kind of is the prostatitic medicine of treatment of crude drug preparation with Chinese medicine.

Background technology

Prostatitis is the normal a kind of diseases of genito-urinary system of suffering from of male adults; age of onset 18～62 years old, its pathogenic factor complexity, can because of often by bike, overworked, drink, factor such as sexual repression or fleshliness causes; this cause of disease acute stages treated is improper, and easily changes into chronic prostatitis.The chronic prostatitis course of disease is slow, and obstinate refractory also can influence sexual function and fertility, and patient's mental burden is heavier, often causes the neurasthenia, and spirit depressing is to such an extent as to hinder one's work and learn.Prostatitic main clinical manifestation is frequent micturition, urgent micturition, dysurea or terminal dribbling and the sense not to the utmost of urine meaning.

The western medical treatment prostatitis does not have good medicine basically at present, and except taking some QIANLIEKANG, medicines such as QIANLIETONG play outside some relief of symptoms effects, venoclysis antibiotic medicine besides, but all have not repercussive phenomenon of antiinflammatory, and the Western medicine toxic and side effects is bigger, as hepatic and renal function is damaged.Also have and adopt local injection, operation to treat, but curative effect is not really remarkable, easily recurrence.Because patient can not obtain the effective treatment, and is worried unusually, often lives among the misery.

Summary of the invention

The purpose of this invention is to provide the prostatitic medicine of a kind of treatment, this medicine has replenishing QI to invigorate the spleen, ascending the clear and descending the turbid, activating QI diuretic effect, is used for the treatment of the prostatitis treating both the principal and secondary aspects of a disease, and is evident in efficacy.

Medicine of the present invention is that crude drug prepares by following parts by weight of traditional Chinese medicines:

Rhizoma Dioscoreae Septemlobae 15～25 Rhizoma Acori Graminei 10～20

Radix Bupleuri 10～20 Fructus Toosendans 10～15

Poria 10～20 Rhizoma Atractylodis Macrocephalaes 10～15

Radix Paeoniae Rubra 10～20 Radix Paeoniae Albas 10～20

Semen Persicae 10～15 Fructus Aurantiis 10～20

Rhizoma Corydalis 10～15 Semen Citri Reticulataes 15～25

Litchi nuclear 15～25 Radix Glycyrrhizaes 5～10.

Said medicine can be made any dosage form on the pharmaceutics, as tablet, pill, powder, capsule etc., the preferred dosage form of the present invention is a capsule.

The concrete preparation method of medicine of the present invention being made capsule is:

With above-mentioned parts of medicines by weight mix homogeneously, decoct with water 3 times, each 1～2 hour, merge 3 times decocting liquid, filter, be condensed into the clear paste of 50 ℃ of relative densities 1.0～1.2, after 50～60 ℃ of dryings, be ground into 100～120 purpose medicated powder, in incapsulating, sterilization makes the capsule product.

Prostatitis belongs to the traditional Chinese medical science " smart turbid ", " stranguria caused by overstrain ", " excessive in vain " category, and main diseases is reluctant to leave and is not gone because of the scorchingly hot heresy of diseases caused by exogenous pathogenic factor is arranged, or sexual behavior is unclean, damp and hot staying in smart chamber, and essence is turbid to be obscured, smart in its position.Because of its kidney fire stagnation does not loose, or damp and hot stagnant for a long time unclear, and smart road stagnation of QI-blood is so delay is difficult.Control suitable heat-clearing and toxic substances removing, inducing diuresis for treating stranguria syndrome, depressed liver-energy dispersing and QI regulating, spleen invigorating dehumidifying, blood-activating analgetic, replenishing QI to invigorate the spleen, ascending the clear and descending the turbid, activating QI diuresis.In the prescription of the present invention ， Rhizoma Dioscoreae Septemlobae dampness removing go turbid, eliminating impediment dispels the wind; Rhizoma Acori Graminei removing dampness appetizing, the eliminating phlegm of having one's ideas straightened out, refreshment Fructus Alpiniae Oxyphyllae; Radix Bupleuri and induce sweat reason, soothing the liver yang invigorating; The circulation of qi promoting of Fructus Toosendan soothing liver-QI, the pain relieving anthelmintic; Poria promoting diuresis to eliminate damp pathogen, spleen invigorating mind calming; Rhizoma Atractylodis Macrocephalae invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis are antiabortive; Radix Paeoniae Rubra, Radix Paeoniae Alba nourishing blood to suppress the hyperactive liver, slow middle pain relieving, yin fluid astringing are received antiperspirant; Semen Persicae blood circulation promoting and blood stasis dispelling, loosening bowel to relieve constipation; Fructus Aurantii regulating the flow of QI to ease the stomach, the stagnant relieving distension of row; Rhizoma Corydalis promoting blood circulation to remove blood stasis, promoting the circulation of QI pain relieving; Semen Citri Reticulatae is regulated the flow of vital energy, eliminating stagnation, pain relieving; Litchi nuclear promoting QI to circulate and dispersing the agglomeration of the pathogens, cold relieving pain relieving; Radix Glycyrrhizae and middle emergency, lung moistening detoxifcation, coordinating the actions of various ingredients in a prescription.All medicines share Yi Rhizoma Dioscoreae Septemlobae, Rhizoma Acori Graminei, heat clearing white peony detoxifcation, inducing diuresis for treating stranguria syndrome, Radix Paeoniae Rubra, Semen Persicae activating blood circulation to dissipate blood stasis, Radix Bupleuri, Fructus Toosendan, Poria, Rhizoma Atractylodis Macrocephalae depressed liver-energy dispersing and QI regulating, spleen invigorating dehumidifying, Fructus Aurantii, Rhizoma Corydalis, Semen Citri Reticulatae, removing obstruction in the collateral to relieve pain, each medicine complements each other, and plays the merit of heat-clearing and toxic substances removing, inducing diuresis for treating stranguria syndrome, depressed liver-energy dispersing and QI regulating, spleen invigorating dehumidifying, blood-activating analgetic, replenishing QI to invigorate the spleen, ascending the clear and descending the turbid, activating QI diuresis altogether, and treatment prostatitis effect is remarkable.

For further investigating the clinical efficacy and the safety of medicine of the present invention, select 120 routine prostatitis patients that the prostatitic curative effect of Drug therapy of the present invention has been carried out clinical observation.

In the 120 routine cases, the oldest 55 years old, minimum 38 years old, the course of disease is the longest 6 years, and was the shortest 1 year, is divided into two groups at random, every group 60 example.Two groups of cases at aspects such as age, the courses of disease by statistics credit analyse the difference not statistically significant, have comparability.All cases are all made a definite diagnosis with reference to prostatitic diagnostic criteria diagnosis in " practical internal medicine ".

Matched group adopts prostatitis drinking particle agent, and 1 dose of every day, boiled water is taken after mixing it with water.The treatment group adopts medicine of the present invention to treat every day 2 times, each 5.2 weeks were 1 course of treatment, treated 4 courses of treatment altogether.

Criterion of therapeutical effect: cure: clinical symptom disappearance, EPS is normal, and the EPS antibacterial culturing is turned out cloudy; Produce effects: the double more preceding minimizing of WBC is more than 1/2 among the EPS, and anus refers to examine the prostate tenderness and disappears, and quality is obviously improved; Effectively: the more preceding minimizing 1/4 of WBC among the EPS, anus refers to examine the prostate tenderness and alleviates; Invalid: WBC does not have improvement among the EPS.

Curative effect comparative result after two groups of cases are treated sees Table 1.

Curative effect after the table 1 liang group case treatment relatively

The specific embodiment

Embodiment 1

Qu Rhizoma Dioscoreae Septemlobae 200g, Rhizoma Acori Graminei 150g, Radix Bupleuri 150g, Fructus Toosendan 120g, Poria 150g, Rhizoma Atractylodis Macrocephalae 120g, Radix Paeoniae Rubra 150g, Radix Paeoniae Alba 150g, Semen Persicae 120g, Fructus Aurantii 150g, Rhizoma Corydalis 120g, Semen Citri Reticulatae 200 grams, litchi nuclear 200g, Radix Glycyrrhizae 80g, the water repeated multiple times cleans up, and decocts with water 3 times, each 1～2 hour, merge 3 times decocting liquid, filter, be condensed into the clear paste of 50 ℃ of relative densities 1.0～1.2, after 50～60 ℃ of dryings, be ground into 100～120 purpose medicated powder, in incapsulating, sterilization makes the capsule product.

Embodiment 2

Qu Rhizoma Dioscoreae Septemlobae 250g, Rhizoma Acori Graminei 180g, Radix Bupleuri 160g, Fructus Toosendan 150g, Poria 150g, Rhizoma Atractylodis Macrocephalae 150g, Radix Paeoniae Rubra 140g, Radix Paeoniae Alba 140g, Semen Persicae 150g, Fructus Aurantii 180g, Rhizoma Corydalis 150g, Semen Citri Reticulatae 240 grams, litchi nuclear 210g, Radix Glycyrrhizae 80g, the water repeated multiple times cleans up, and decocts with water 3 times, each 1～2 hour, merge 3 times decocting liquid, filter, be condensed into the clear paste of 50 ℃ of relative densities 1.0～1.2, after 50～60 ℃ of dryings, be ground into 100～120 purpose medicated powder, in incapsulating, sterilization makes the capsule product.

Claims

1. treating prostatitic medicine for one kind, is that crude drug prepares by following parts by weight of traditional Chinese medicines:

2. the prostatitic medicine of treatment according to claim 1 is characterized in that described medicine is made capsule.

3. the preparation method of the prostatitic medicine of the described treatment of claim 2, be with above-mentioned parts of medicines by weight mix homogeneously, decoct with water 3 times, each 1～2 hour, merge 3 times decocting liquid, filter, be condensed into the clear paste of 50 ℃ of relative densities 1.0～1.2, after 50～60 ℃ of dryings, be ground into 100～120 purpose medicated powder, in incapsulating, sterilization makes the capsule product.